Get Sample Pages - Oncolytic Virus Therapy Market Demand, and Growth Statistics 2022-2027

Global Oncolytic Virus Therapy Market Research Report: Forecast (2022-2027)

Oncolytic Virus Therapy Market - By Therapy (IMLYGIC {Talimogene Laherparepvec}, Oncorine, RIGVIR Immunotherapy, Onyx-15, Reolysin), By Application (Solid Tumor [Breast Cancer, Pro......state Cancer, Lung Cancer, Glioblastoma/Glioblastoma Multiforme], Melanoma, Hematological Malignancies [Lymphoma, Leukemia, Myeloma]), By Type of Virus (Genetically Engineered Oncolytic Virus [Herpes Simplex Virus{HSV}, Adenovirus, Vaccinia Virus], Oncolytic Wild Type of Viruses [Myxoma, Vesicular Stomatitis Virus {VSV}, Newcastle Disease Virus {NDV}, Reovirus {Respiratory Enteric Orphan Virus}]), By End User (Hospitals, Clinics, Patients, Cancer Research Institutes) and Others Read more

Healthcare
Nov 2021
Pages 221
Report Format: PDF, Excel, PPT

Oncolytic Viruses (OVs) are genetically engineered or naturally occurring viruses that selectively target & kill cancer cells without harming the normal tissues. This therapy is a new therapeutic procedure to treat cancer patients and has presented promising outcomes worldwide.

According to MarkNtel Advisors, the Global Oncolytic Virus Therapy Market is projected to grow at a CAGR of around 20.3% during the forecast period i.e. 2022-27. The market is driven primarily by the mounting prevalence of cancer worldwide and the surging number of clinical trials & R&D investments for cancer therapies.

Moreover, the burgeoning focus of the governments in both developed & emerging countries on reducing mortality & morbidity rates by conducting various awareness campaigns toward encouraging people to opt for early diagnosis has increased the patient pool of oncolytic virus therapies. Hence, in the coming years, the global market is projected to significantly grow and create lucrative growth opportunities for the leading players in the market.

Report Coverage	Details
Study Period	Historical Data: 2017-20
	Base Year: 2021
	Forecast Period: 2022-27
CAGR (2022-2027)	20.3%
Regions Covered	North America: USA, Canada, Mexico
	Europe: Germany, UK, France, Italy, Spain
	Asia-Pacific: China, India, Japan, Australia
	South America: Brazil, and Argentina
	Middle East & Africa: UAE, Saudi Arabia, South Africa
Key Companies Profiled	Amgen Inc., Daiichi Sankyo Company Limited, DNAtrix, Genelux Corporation, Oncolytics Biotech Inc., PsiOxus Therapeutics, RIGVIR Ltd., Shanghai Sunway Biotech Co. Ltd., SillaJen Inc., Sorrento Therapeutics Inc., Takara Bio Inc., Lokon Pharma AB, VCN Biosciences, ViroCure Inc., Viralytics Ltd. (Merck & Co. Inc.)
Unit Denominations	USD Million/Billion

Impact of Covid-19 on the Global Oncolytic Virus Therapy Market

The Covid-19 pandemic in 2020 brought the entire healthcare sector under extensive pressure.
It made many nations realize that their healthcare infrastructure wasn't prepared or sufficient enough to handle such a large influx of very sick Covid-19 patients.
Overcrowded emergency rooms, which were initially feared, turned into reality across many communities.
However, the mounting need for an effective vaccine against the coronavirus and continued R&D on using Oncolytic Virus therapies to fight the Covid-19 infection helped the market remain steady amidst the crisis.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Global Oncolytic Virus Therapy Market Policies, Regulations, and Product Standards
Global Oncolytic Virus Therapy Market Value Chain Analysis
Global Oncolytic Virus Therapy Market Trends & Developments
Global Oncolytic Virus Therapy Market Dynamics
1. Growth Drivers
2. Challenges
Global Oncolytic Virus Therapy Market Hotspot & Opportunities
Global Oncolytic Virus Therapy Market Outlook, 2020-2030F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Therapy
    1. IMLYGIC (Talimogene Laherparepvec)- Market Size & Forecast 2020-2030, USD Million
    2. Oncorine- Market Size & Forecast 2020-2030, USD Million
    3. RIGVIR Immunotherapy- Market Size & Forecast 2020-2030, USD Million
    4. Onyx-15- Market Size & Forecast 2020-2030, USD Million
    5. Reolysin- Market Size & Forecast 2020-2030, USD Million
  2. By Application
    1. Solid Tumor- Market Size & Forecast 2020-2030, USD Million
      1. Breast Cancer- Market Size & Forecast 2020-2030, USD Million
      2. Prostate Cancer- Market Size & Forecast 2020-2030, USD Million
      3. Lung Cancer- Market Size & Forecast 2020-2030, USD Million
      4. Glioblastoma/Glioblastoma Multiforme- Market Size & Forecast 2020-2030, USD Million
    2. Melanoma- Market Size & Forecast 2020-2030, USD Million
    3. Hematological Malignancies- Market Size & Forecast 2020-2030, USD Million
      1. Lymphoma- Market Size & Forecast 2020-2030, USD Million
      2. Leukemia- Market Size & Forecast 2020-2030, USD Million
      3. Myeloma- Market Size & Forecast 2020-2030, USD Million
  3. By Type of Virus
    1. Genetically Engineered Oncolytic Virus- Market Size & Forecast 2020-2030, USD Million
      1. Herpes Simplex Virus(HSV)- Market Size & Forecast 2020-2030, USD Million
      2. Adenovirus- Market Size & Forecast 2020-2030, USD Million
      3. Vaccinia Virus- Market Size & Forecast 2020-2030, USD Million
    2. Oncolytic Wild Type of Viruses- Market Size & Forecast 2020-2030, USD Million
      1. Myxoma- Market Size & Forecast 2020-2030, USD Million
      2. Vesicular Stomatitis Virus (VSV)- Market Size & Forecast 2020-2030, USD Million
      3. Newcastle Disease Virus (NDV)- Market Size & Forecast 2020-2030, USD Million
      4. Reovirus (Respiratory Enteric Orphan Virus)- Market Size & Forecast 2020-2030, USD Million
  4. By End User
    1. Hospitals- Market Size & Forecast 2020-2030, USD Million
    2. Clinics- Market Size & Forecast 2020-2030, USD Million
    3. Patients- Market Size & Forecast 2020-2030, USD Million
    4. Cancer Research Institutes- Market Size & Forecast 2020-2030, USD Million
  5. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East and Africa
    5. Asia-Pacific
  6. By Company
    1. Company Revenue Shares
    2. Competitor Characteristics
North America Oncolytic Virus Therapy Market Outlook, 2020-2030F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Therapy- Market Size & Forecast 2020-2030, USD Million
  2. By Application- Market Size & Forecast 2020-2030, USD Million
  3. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
  4. By End User- Market Size & Forecast 2020-2030, USD Million
  5. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
4. Canada Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
5. Mexico Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
South America Oncolytic Virus Therapy Market Outlook, 2020-2030F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Therapy- Market Size & Forecast 2020-2030, USD Million
  2. By Application- Market Size & Forecast 2020-2030, USD Million
  3. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
  4. By End User- Market Size & Forecast 2020-2030, USD Million
  5. By Country
    1. Brazil
    2. Argentina
    3. Rest of South America
3. Brazil Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
4. Argentina Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
Europe Oncolytic Virus Therapy Market Outlook, 2020-2030F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Therapy- Market Size & Forecast 2020-2030, USD Million
  2. By Application- Market Size & Forecast 2020-2030, USD Million
  3. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
  4. By End User- Market Size & Forecast 2020-2030, USD Million
  5. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Rest of Europe
3. The UK Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
4. Germany Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
5. France Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
6. Italy Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
7. Spain Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
Middle East & Africa Oncolytic Virus Therapy Market Outlook, 2020-2030F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Therapy- Market Size & Forecast 2020-2030, USD Million
  2. By Application- Market Size & Forecast 2020-2030, USD Million
  3. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
  4. By End User- Market Size & Forecast 2020-2030, USD Million
  5. By Country
    1. Saudi Arabia
    2. The UAE
    3. South Africa
    4. Rest of Middle East & Africa
3. Saudi Arabia Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
4. The UAE Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
5. South Africa Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
Asia Pacific Oncolytic Virus Therapy Market Outlook, 2020-2030F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Therapy- Market Size & Forecast 2020-2030, USD Million
  2. By Application- Market Size & Forecast 2020-2030, USD Million
  3. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
  4. By End User- Market Size & Forecast 2020-2030, USD Million
  5. By Country
    1. China
    2. Japan
    3. India
    4. Australia
    5. Rest of Asia Pacific
3. China Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
4. Japan Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
5. India Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
6. Australia Oncolytic Virus Therapy Market Outlook, 2020-2030F
  1. Market Size & Outlook
    1. By Revenues (USD Million)
  2. Market Share & Outlook
    1. By Therapy- Market Size & Forecast 2020-2030, USD Million
    2. By Type of Virus- Market Size & Forecast 2020-2030, USD Million
Global Oncolytic Virus Therapy Market Key Strategic Imperatives for Success & Growth
Competition Outlook
1. Company Profiles
  1. Amgen Inc.
    1. Business Description
    2. Service Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Daiichi Sankyo Company Limited
    1. Business Description
    2. Service Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. DNAtrix
    1. Business Description
    2. Service Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Genelux Corporation
    1. Business Description
    2. Service Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Oncolytics Biotech Inc.
    1. Business Description
    2. Service Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. PsiOxus Therapeutics
    1. Business Description
    2. Service Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. RIGVIR Ltd.
    1. Business Description
    2. Service Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Shanghai Sunway Biotech Co. Ltd.
    1. Business Description
    2. Service Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. SillaJen Inc.
    1. Business Description
    2. Service Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Sorrento Therapeutics Inc.
    1. Business Description
    2. Service Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  11. Takara Bio Inc.
    1. Business Description
    2. Service Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  12. Lokon Pharma AB
    1. Business Description
    2. Service Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  13. VCN Biosciences
    1. Business Description
    2. Service Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  14. ViroCure Inc.
    1. Business Description
    2. Service Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  15. Viralytics Ltd. (Merck & Co. Inc.)
    1. Business Description
    2. Service Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  16. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Name *

Email ID *

Country *